ChemPartner Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
2,076
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
- Investments
-
4
ChemPartner General Information
Description
Operator of a research organization intended to offer high-quality and cost-effective services to the biopharmaceutical industry. The company offers a broad range of integrated services across the drug discovery and development process, enabling it to serve the pharmaceutical and biotechnology companies around the globe.
Contact Information
Website
www.chempartner.com(Operating Subsidiary)
Corporate Office
- 1F & 3F, Block A, 2829 JinKe Road
- Zhangjiang Hi-Tech Park, PuDong New Area
- Shanghai, 201203
- China
Corporate Office
- 1F & 3F, Block A, 2829 JinKe Road
- Zhangjiang Hi-Tech Park, PuDong New Area
- Shanghai, 201203
- China
ChemPartner Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
ChemPartner Comparisons
Industry
Financing
Details
ChemPartner Competitors (55)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Shanghai Medicilon | Formerly VC-backed | Shanghai, China | ||||
KBI BioPharma | Formerly VC-backed | Durham, NC | ||||
Dalton Pharma Services | Corporate Backed or Acquired | Toronto, Canada | ||||
Syngene International | Formerly PE-Backed | Bangalore, India | ||||
Pharmaron | Formerly VC-backed | Beijing, China |
ChemPartner Patents
ChemPartner Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3164325-A1 | Alpha-5 beta-1 inhibitors | Pending | 10-Dec-2019 | ||
US-20210171455-A1 | Alpha-5 beta-1 inhibitors | Active | 10-Dec-2019 | ||
AU-2020401188-A1 | Alpha-5 beta-1 inhibitors | Pending | 10-Dec-2019 | ||
US-11530180-B2 | Alpha-5 beta-1 inhibitors | Active | 10-Dec-2019 | ||
EP-4072541-A1 | Alpha-5 beta-1 inhibitors | Pending | 10-Dec-2019 | C07C279/18 |
ChemPartner Executive Team (7)
Name | Title | Board Seat |
---|---|---|
Xianwei Zeng | Chairman & Chief Executive Officer | |
Michael Hui | Chief Executive Officer | |
Walter Moos Ph.D | Chief Executive Officer, ShangPharma Innovation |
ChemPartner Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
ChemPartner | Chairman & Chief Executive Officer |
ChemPartner Signals
ChemPartner Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
ChemPartner Investments (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Circle Pharma | 02-Dec-2018 | Drug Discovery | |||
Circle Pharma | 25-Apr-2017 | Drug Discovery | |||
Morphic Therapeutic | 30-Jun-2016 | Drug Discovery | |||
Morphic Therapeutic | 01-Jun-2015 | Seed Round | Drug Discovery |
ChemPartner FAQs
-
When was ChemPartner founded?
ChemPartner was founded in 2002.
-
Who is the CEO of ChemPartner?
Xianwei Zeng, Michael Hui, and Walter Moos Ph.D are the CEOs of ChemPartner.
-
Where is ChemPartner headquartered?
ChemPartner is headquartered in Shanghai, China.
-
What is the size of ChemPartner?
ChemPartner has 2,076 total employees.
-
What industry is ChemPartner in?
ChemPartner’s primary industry is Drug Discovery.
-
Is ChemPartner a private or public company?
ChemPartner is a Private company.
-
What is the current valuation of ChemPartner?
The current valuation of ChemPartner is
. -
What is ChemPartner’s current revenue?
The current revenue for ChemPartner is
. -
How much funding has ChemPartner raised over time?
ChemPartner has raised $122M.
-
Who are ChemPartner’s investors?
TPG has invested in ChemPartner.
-
Who are ChemPartner’s competitors?
Shanghai Medicilon, KBI BioPharma, Dalton Pharma Services, Syngene International, and Pharmaron are some of the 55 competitors of ChemPartner.
-
When was ChemPartner acquired?
ChemPartner was acquired on 16-Aug-2018.
-
Who acquired ChemPartner?
ChemPartner was acquired by Quantum Hi-Tech (China) Biological Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »